Ariel Kenig

412 total citations
19 papers, 303 citations indexed

About

Ariel Kenig is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Ariel Kenig has authored 19 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in Ariel Kenig's work include COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Platelet Disorders and Treatments (2 papers). Ariel Kenig is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Platelet Disorders and Treatments (2 papers). Ariel Kenig collaborates with scholars based in Israel and United States. Ariel Kenig's co-authors include Yaron Ilan, Fadi Kharouf, Limor Rubin, Radgonde Amer, Rabea Asleh, Offer Amir, Oded Meyuhas, Oded Volovelsky, Tally Naveh‐Many and Avigail Dreazen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Society of Nephrology and Lara D. Veeken.

In The Last Decade

Ariel Kenig

18 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ariel Kenig Israel 8 99 86 34 32 31 19 303
Yijun Dong China 10 103 1.0× 38 0.4× 33 1.0× 43 1.3× 19 0.6× 35 325
Chaoyang Chen China 13 78 0.8× 64 0.7× 28 0.8× 66 2.1× 16 0.5× 41 397
Lili Qu United States 9 85 0.9× 81 0.9× 22 0.6× 30 0.9× 35 1.1× 15 340
Rachel Njeim Lebanon 9 69 0.7× 41 0.5× 32 0.9× 19 0.6× 18 0.6× 19 261
Milijana Janjusevic Italy 12 92 0.9× 51 0.6× 32 0.9× 43 1.3× 24 0.8× 29 438
Mariana Dupont United States 9 137 1.4× 57 0.7× 31 0.9× 62 1.9× 29 0.9× 17 301
Cem Haymana Türkiye 12 77 0.8× 76 0.9× 74 2.2× 40 1.3× 23 0.7× 45 433
Ali Nasir Siddiqui India 12 64 0.6× 78 0.9× 79 2.3× 27 0.8× 15 0.5× 19 353
Vanessa Williams United States 10 147 1.5× 51 0.6× 31 0.9× 19 0.6× 16 0.5× 19 397
Yuyou Zhu China 9 105 1.1× 86 1.0× 34 1.0× 41 1.3× 101 3.3× 23 416

Countries citing papers authored by Ariel Kenig

Since Specialization
Citations

This map shows the geographic impact of Ariel Kenig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel Kenig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel Kenig more than expected).

Fields of papers citing papers by Ariel Kenig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariel Kenig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel Kenig. The network helps show where Ariel Kenig may publish in the future.

Co-authorship network of co-authors of Ariel Kenig

This figure shows the co-authorship network connecting the top 25 collaborators of Ariel Kenig. A scholar is included among the top collaborators of Ariel Kenig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariel Kenig. Ariel Kenig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kenig, Ariel, et al.. (2024). Apoptotic Cell–Based Therapy for the Modification of the Inflammatory Response to Hemorrhagic Shock. Military Medicine. 189(Supplement_3). 416–422. 1 indexed citations
2.
Kenig, Ariel, et al.. (2023). Low-Dose Colchicine Attenuates Sepsis-Induced Liver Injury: A Novel Method for Alleviating Systemic Inflammation. Inflammation. 46(3). 963–974. 6 indexed citations
3.
Kenig, Ariel, et al.. (2023). Serum Levels of Adropin Improve the Predictability of MELD and Child-Pugh Score in Cirrhosis: Results of Proof-of-Concept Clinical Trial. Transplant International. 36. 11176–11176. 2 indexed citations
4.
Kharouf, Fadi, et al.. (2023). Increased rates of idiopathic inflammatory myopathies during the COVID-19 pandemic: a single-centre experience. Clinical and Experimental Rheumatology. 41(2). 316–321. 11 indexed citations
5.
Kenig, Ariel, et al.. (2023). Colchicine at a Low Dose Reduces Liver Inflammation in a Model of Immune-Mediated Hepatitis. Archives of Clinical and Biomedical Research. 7(2). 1 indexed citations
6.
Kenig, Ariel, Yonatan Oster, Ronit Cohen‐Poradosu, et al.. (2022). Characteristics of endovascular pneumococcal infections; a decade of nationwide surveillance study. European Journal of Clinical Microbiology & Infectious Diseases. 41(11). 1365–1370.
7.
Kenig, Ariel, et al.. (2022). Use of Colchicine for Pericardial Inflammation. JACC Case Reports. 4(21). 1449–1452. 2 indexed citations
8.
Kenig, Ariel, et al.. (2022). Autoimmune Diseases Induced or Exacerbated by COVID-19: A Single Center Experience. Autoimmune Diseases. 2022. 1–7. 2 indexed citations
9.
Kenig, Ariel, et al.. (2022). Massive Intestinal Bleeding in an Adult with IgA Vasculitis Treated with Intravenous Immunoglobulin. SHILAP Revista de lepidopterología. 2022. 1–4. 2 indexed citations
10.
Kenig, Ariel, et al.. (2021). Improving Diuretic Response in Heart Failure by Implementing a Patient-Tailored Variability and Chronotherapy-Guided Algorithm. Frontiers in Cardiovascular Medicine. 8. 695547–695547. 37 indexed citations
11.
Kenig, Ariel, et al.. (2021). Autoimmune phenomena following SARS-CoV-2 vaccination. International Immunopharmacology. 99. 107970–107970. 64 indexed citations
12.
Kenig, Ariel, et al.. (2021). Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products. Clinical Immunology. 227. 108723–108723. 22 indexed citations
13.
Kharouf, Fadi, et al.. (2021). Incidence and course of COVID-19 hospitalizations among patients with familial Mediterranean fever. Lara D. Veeken. 60(SI). SI85–SI89. 7 indexed citations
14.
Kenig, Ariel, et al.. (2021). An Adult with Recurrent Severe Pneumococcal Pneumonia Secondary to Prolidase Deficiency.. PubMed. 23(3). 193–195. 1 indexed citations
15.
Kenig, Ariel, et al.. (2020). Blood cultures of adult patients discharged from the emergency department—is the safety net reliable?. European Journal of Clinical Microbiology & Infectious Diseases. 39(7). 1261–1269. 1 indexed citations
16.
Kenig, Ariel, et al.. (2020). An immunocompetent patient with culture-negative multiple brain abscesses caused by Fusobacterium nucleatum. Anaerobe. 65. 102261–102261. 3 indexed citations
17.
Kenig, Ariel, et al.. (2020). Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy. Pharmacology Research & Perspectives. 8(4). e00616–e00616. 58 indexed citations
18.
Kenig, Ariel & Yaron Ilan. (2019). A Personalized Signature and Chronotherapy-Based Platform for Improving the Efficacy of Sepsis Treatment. Frontiers in Physiology. 10. 1542–1542. 55 indexed citations
19.
Volovelsky, Oded, Ariel Kenig, Avigail Dreazen, et al.. (2015). Phosphorylation of Ribosomal Protein S6 Mediates Mammalian Target of Rapamycin Complex 1–Induced Parathyroid Cell Proliferation in Secondary Hyperparathyroidism. Journal of the American Society of Nephrology. 27(4). 1091–1101. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026